Peter De Muth Angion Biomedica Corp. (ANGN) insider trading activity
Peter De Muth is Chief Scientific Officer of Angion Biomedica Corp.. Currently has a direct ownership of 381 shares of ANGN, which is worth approximately $0. The most recent transaction as insider was on Dec 16, 2024, when has been sold 381 shares (Common Stock) at a price of $4.41 per share, resulting in proceeds of $1,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
381
n/a
3M change
n/a
12M change
Total Value Held
$0
PD
Peter De Muth
Chief Scientific Officer
Boston, MA